Lindsay J Norton, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Moosehead Trl Ste 5, Newport, ME 04953 Phone: 207-368-5189 Fax: 207-368-2451 |
John C Baker, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 26 Main St, Suite 2, Newport, ME 04953 Phone: 207-368-5747 Fax: 207-368-5483 |
Steven J Badeen, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 8 Main St, Newport, ME 04953 Phone: 207-368-4292 Fax: 207-368-4250 |
Karl F. Sitterly, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 26 Main St, Suite 2, Newport, ME 04953 Phone: 207-368-5747 Fax: 207-368-5483 |
News Archive
In comments submitted to the Centers for Medicare and Medicaid Services, the American College of Rheumatology expressed its continuing concern with a recent CMS policy allowing Medicare Advantage plans to utilize step therapy for Part B drugs.
New research indicates that Mexican-Americans born in the United States who are aged 55 and over are significantly more likely than Mexican-American immigrants to report that they have substantial limitations in one or more basic physical activities such as walking, climbing stairs, reaching, lifting, or carrying. (30% versus 25%).
House Democrats say their health overhaul proposal will lead to health insurance premium savings for many consumers, though estimates of the overall measure's cost, as well as the taxes and fees required to pay for it, is a source of criticism and concern.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,781,160 entitled "Biomarkers Related to Metabolic Age and Methods Using the Same". The USPTO awarded the patent to Metabolon on August 24, 2010. This is the 12th patent issued to Metabolon.
In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.
› Verified 9 days ago